Alector (ALEC) EBT Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,688.00 |
| 10 | Alector | 238.87 Mn | 32.36 Mn | - | -109,061.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109,061.00 |
| Dec 31, 2025 | -59,109.00 |
| Sep 30, 2025 | -78,821.00 |
| Jun 30, 2025 | -13,172.00 |
| Mar 31, 2025 | -87,458.00 |
| Dec 31, 2024 | 25,807.00 |
| Sep 30, 2024 | 19,932.00 |
| Jun 30, 2024 | -26,086.00 |
| Mar 31, 2024 | 4,469.00 |
| Dec 31, 2023 | 9,628.00 |
| Sep 30, 2023 | -16,872.00 |
| Jun 30, 2023 | -876.00 |
| Mar 31, 2023 | -9,245.00 |
| Dec 31, 2022 | 3,929.00 |
| Sep 30, 2022 | -37,519.00 |
| Jun 30, 2022 | 85,331.00 |
| Mar 31, 2022 | 109,016.00 |
| Dec 31, 2021 | -250,881.00 |
| Sep 30, 2021 | 97,978.00 |
| Jun 30, 2021 | 63,005.00 |
| Mar 31, 2021 | -68,259.00 |
| Dec 31, 2020 | 265,038.00 |
| Sep 30, 2020 | 35,627.00 |
| Jun 30, 2020 | -107,714.00 |
| Mar 31, 2020 | -21,638.00 |
| Dec 31, 2019 | -33,099.00 |
| Sep 30, 2019 | -100,808.00 |
| Jun 30, 2019 | -22,049.00 |
| Mar 31, 2019 | -18,290.00 |